Hei,
Vuoden 2021 riskiarvioinnit pitäisi tehdä (kemiallinen ja biologinen). ASA-aineille altistumiset pyydän myöhemmin. Tehkää riskiarvioinnit kuten aiemmin ja tallentakaa riskiarvioinnit kansioon:
ltk-yhteiset\KLIIN\CRC\Riskiarviointi Risk assessment
Ko riskiarvioinnit pitäisi tehdä viimeistään 4.2.2022. Lisäinfoa riskienarvioinneista löytyy:
https://patio.oulu.fi/fi/palvelut-ja-ohjeet/henkilosto/tyosuojelu/tyosuojel…
Hi,
It is time to do risk assessments (chemical and biological) for 2021. Exposures to ASA chemicals I will ask later. Do these risk assessments as previously and save your risk assessments in a folder:
ltk-yhteiset\KLIIN\CRC\Riskiarviointi Risk assessment
The risk assessments should be done no later than 4.2.2022. More information of risk assessments can be found:
https://patio.oulu.fi/en/services-and-instructions/personnel/occupational-s…
Terv. Antti Haapalainen
From: Virpi Glumoff <virpi.glumoff(a)oulu.fi>
Sent: maanantai 31. tammikuuta 2022 19.38
To: LTK <ltk-staff(a)oulu.fi>; LTK-idm <LTK-idm(a)oulu.fi>; fbmm <fbmm(a)lists.oulu.fi>; bco(a)lists.oulu.fi (bco(a)lists.oulu.fi) <bco(a)lists.oulu.fi>; 'biolaaket(a)lists.oulu.fi' <biolaaket(a)lists.oulu.fi>
Subject: FW: Single Cell analysis and BD Rhapsody introduction webinar 8.2. between 10-11
FYI
-virpi
From: Noora ALLONEN <Noora.ALLONEN(a)bd.com<mailto:Noora.ALLONEN@bd.com>>
Sent: Monday, 31 January 2022 14.26
To: Virpi Glumoff <virpi.glumoff(a)oulu.fi<mailto:virpi.glumoff@oulu.fi>>
Subject: Single Cell analysis and BD Rhapsody introduction webinar 8.2. between 10-11
Please find here information and participation link to BD Single Cell Analysis solution and BD Rhapsody introduction webinar!
Warmly welcome to join and hear more about the exiting method!
[cid:image001.png@01D816AC.C5AF84F0]
Microsoft Teams meeting
Join on your computer or mobile app
Click here to join the meeting<https://teams.microsoft.com/l/meetup-join/19%3ameeting_NTc5NGRlMGUtMGY1Yy00…>
Join with a video conferencing device
teams(a)vc.bd.com<mailto:teams@vc.bd.com>
Video Conference ID: 119 122 968 9
Alternate VTC instructions<https://vc.bd.com/teams/?conf=1191229689&ivr=teams&d=vc.bd.com&ip=204.193.3…>
Or call in (audio only)
+358 9 85626476,,987244656#<tel:+358985626476,,987244656#> Finland, Helsinki
Phone Conference ID: 987 244 656#
Find a local number<https://dialin.teams.microsoft.com/d9a9a0de-2351-4bd4-9ddc-f03fd23fbdcb?id=…> | Reset PIN<https://mysettings.lync.com/pstnconferencing>
Yst.terv, Noora
[cid:image002.gif@01D816AC.C5AF84F0]<https://lp.bd.com/202012-BDB21-UKI_EN-Immune_Systems-LP_LP-EN-01-MainLP.htm…>
[cid:image003.png@01D816AC.C5AF84F0]
Noora Allonen, M.Sci.
Technical Sales Representative, Finland
BD Biosciences
Äyritie 18, 01510 Vantaa, Finland
Tel. +358 44 3083330
Email. Noora.allonen(a)bd.com<mailto:Noora.allonen@bd.com>
www.bdbiosciences.com<http://www.bdbiosciences.com/>
________________________________
Becton Dickinson OY
Äyritie 18
01510 Vantaa, Finland
Y-tunnus: 0770864-2 VAT no. FI07708642
This message (which includes any attachments) is intended only for the designated recipient(s). It may contain confidential or proprietary information and may be subject to legal privilege or other confidentiality protections. If you are not a designated recipient, you may not review, use, copy or distribute this message. If you received this communication in error, please notify the sender by reply e-mail and delete this message. Thank You!
________________________________
*******************************************************************
IMPORTANT MESSAGE FOR RECIPIENTS IN THE U.S.A.:
This message may constitute an advertisement of a BD group's products or services or a solicitation of interest in them. If this is such a message and you would like to opt out of receiving future advertisements or solicitations from this BD group, please forward this e-mail to optoutbygroup(a)bd.com<mailto:optoutbygroup@bd.com>. [BD.v1.0]
*******************************************************************
This message (which includes any attachments) is intended only for the designated recipient(s). It may contain confidential or proprietary information and may be subject to the attorney-client privilege or other confidentiality protections. If you are not a designated recipient, you may not review, use, copy or distribute this message. If you received this in error, please notify the sender by reply e-mail and delete this message. Thank you.
*******************************************************************
Corporate Headquarters Mailing Address: BD (Becton, Dickinson and Company) 1 Becton Drive Franklin Lakes, NJ 07417 U.S.A.